NASDAQ
No price data available for this timeframe.
ANI Pharmaceuticals, Inc. (ANIP) has had 16 insider transactions recently, with net insider activity of -$57K (net selling). The most active insider is Shanmugam Muthusamy (Director, officer: head of r&d, coo-novitium ops).
Total Transactions
16
6 buys /10 sells
Shares Acquired
25,097
Transactions: 6•Avg: 4,182.83
Shares Disposed
81,828
Transactions: 10•Avg: 8,182.8
Net Activity
-56,731
Net Selling•Ratio: 60%
Q2 2026(Current) | 25,097 | 81,828 | -56,731 | 60.00% |
Q1 2026 | 188,370 | 217,821 | -29,451 | 17.86% |
Q4 2025 | 0 | 31,001 | -31,001 | 0.00% |
Q3 2025 | 50,000 | 467,611 | -417,611 | 4.00% |
Q2 2025 | 26,016 | 6,781 | +19,235 | 100.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q2 2026
Acquired vs Disposed Shares
Net Distribution: 56,731 shares•Acquired/Disposed Ratio: 60%
Net Activity | |||||
|---|---|---|---|---|---|
SM Shanmugam Muthusamy | Director, officer: head of r&d, coo-novitium ops | 4 | 11,116 | 102,898 | -91,782 |
LN Lalwani Nikhil | Director, officer: president & ceo | 7 | 75,592 | 136,922 | -61,330 |
WPD Walsh Patrick D | Director | 5 | 0 | 31,616 | -31,616 |
MC Mutz Christopher | Officer: head of rare disease | 12 | 21,306 | 37,314 | -16,008 |
GC Gassert Chad | Officer: svp - corp. dev. & strategy | 7 | 11,116 | 24,551 | -13,435 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2026-06-12 | Officer: sr. vp, general counsel & sec. | Sale | 500 | $82.03 | $41,015 | 77,890 | |
2026-05-21 | Director | Purchase | 4,357 | $0 | $0 | 27,762 | |
2026-05-21 | Director | Purchase | 4,357 | $0 | $0 | 29,514 | |
2026-05-21 | Director | Purchase | 4,357 | $0 | $0 | 27,017 | |
2026-05-21 | Director | Purchase | 4,357 | $0 | $0 | 11,221 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
CM Cook Meredith | Officer: sr. vp, general counsel & sec. | Jun 15, 2026 | |
TJ Thoma Jeanne | Director | Jun 10, 2026 | |
TRP TANNENBAUM RENEE P | Director | Jun 10, 2026 | |
PAR Pera Antonio R | Director | Jun 10, 2026 | |
LMJ Leonard Matthew J | Director | Jun 10, 2026 |
Net change in shares shown on right